The NLRP1 Inflammasome Attenuates Colitis and Colitis-Associated Tumorigenesis
Open accessThe DOI matches its Crossref record; 61 of the 62 references it cites were found in a registry or an index.
Abstract
Nucleotide-binding domain and leucine-rich repeat (NLR) proteins are a diverse family of pattern recognition receptors that are essential mediators of inflammation and host defense in the gastrointestinal system. Recent studies have identified a subgroup of inflammasome forming NLRs that modulate the mucosal immune response during inflammatory bowel disease (IBD) and colitis associated tumorigenesis. To better elucidate the contribution of NLR family members in IBD and cancer, we conducted a retrospective analysis of gene expression metadata from human patients. These data revealed that NLRP1, an inflammasome forming NLR, was significantly dysregulated in IBD and colon cancer. To better characterize the function of NLRP1 in disease pathogenesis, we used Nlrp1b(-/-) mice in colitis and colitis-associated cancer models. In this paper, we report that NLRP1 attenuates gastrointestinal inflammation and tumorigenesis. Nlrp1b(-/-) mice demonstrated significant increases in morbidity, inflammation, and tumorigenesis compared with wild-type animals. Similar to data previously reported for related inflammasome forming NLRs, the increased inflammation and tumor burden was correlated with attenuated levels of IL-1β and IL-18. Further mechanistic studies using bone marrow reconstitution experiments revealed that the increased disease pathogenesis in the Nlrp1b(-/-) mice was associated with nonhematopoietic-derived cells and suggests that NLRP1 functions in the colon epithelial cell compartment to attenuate tumorigenesis. Taken together, these data identify NLRP1 as an essential mediator of the host immune response during IBD and cancer. These findings are consistent with a model whereby multiple NLR inflammasomes attenuate disease pathobiology through modulating IL-1β and IL-18 levels in the colon.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Commensal bacteria and their bioproducts induce inflammasomes activation and IL-18 production in the gut, which, in turn, prevents intestinal barrier disruption and dysbiosis [121,124,131,132,133].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [132]
Experimental — accuracy not yet measuredIn the citing paper
“Dysbiosis has been observed in mice deficient for inflammasomes components, including NLRP6, ASC, caspase-1, and IL-18 [131,132,133,134].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [132]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Martinon, F., Burns, K., & Tschopp, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00599-3 · Cited by 6,066 · cited 4×
“Although exposure to either T. gondii or LeTx are unlikely mediators of IBD pathogenesis, further characterization of NLRP1 will likely identify a range of additional MAMPs and DAMPs of greater relevance to gastrointestinal inflammation and cancer.”
InfluentialSchroder, K., & Tschopp, J. (2010) · Cell · doi:10.1016/j.cell.2010.01.040 · Cited by 5,475
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis
Elinav, E., Strowig, T., Kau, A. L., Henao-Mejia, J., Thaiss, C. A., Booth, C. J., Peaper, D. R., Bertin, J., Eisenbarth, S. C., Gordon, J. I., et al. (2011) · Cell · doi:10.1016/j.cell.2011.04.022 · Cited by 2,024 · cited 4×
“For example, the commensal microbiota composition in the Nlrp6 mice was found to be significantly altered compared with WT animals, and this distorted microbiota was suggested to be directly associated with disease pathogenesis in IBD (6, 14).”
BackgroundResultInfluentialAcosta-Rodriguez, E. V., Napolitani, G., Lanzavecchia, A., & Sallusto, F. (2007) · Nature Immunology · doi:10.1038/ni1496 · Cited by 1,857
Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf
Mariathasan, S., Newton, K., Monack, D. M., Vucic, D., French, D. M., Lee, W. P., Roose-Girma, M., Erickson, S., & Dixit, V. M. (2004) · Nature · doi:10.1038/nature02664 · Cited by 1,839
Chemically induced mouse models of intestinal inflammation
Wirtz, S., Neufert, C., Weigmann, B., & Neurath, M. F. (2007) · Nature Protocols · doi:10.1038/nprot.2007.41 · Cited by 1,567 · cited 2×
“5 or 5% DSS (MP Biomedicals) for 4–5 d and the mice were evaluated for up 10 d (33).”
BackgroundSutton, C. E., Lalor, S. J., Sweeney, C. M., Brereton, C. F., Lavelle, E. C., & Mills, K. H. G. (2009) · Immunity · doi:10.1016/j.immuni.2009.08.001 · Cited by 1,553
Critical Regulation of Early Th17 Cell Differentiation by Interleukin-1 Signaling
Chung, Y., Chang, S. H., Martinez, G. J., Yang, X. O., Nurieva, R., Kang, H. S., Ma, L., Watowich, S. S., Jetten, A. M., Tian, Q., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.02.007 · Cited by 1,199
Zaki, M. H., Boyd, K. L., Vogel, P., Kastan, M. B., Lamkanfi, M., & Kanneganti, T.-D. (2010) · Immunity · doi:10.1016/j.immuni.2010.03.003 · Cited by 989 · cited 3×
“Specifically, Asc(2) /2 and Casp1/11 mice develop severe gastrointestinal inflammation and colon tumorigenesis in AOM/DSS models (4, 5, 8).”
BackgroundResult
Cited by
Items 101–162 of 162
AIM2 inflammasome activation benefits the therapeutic effect of BCG in bladder carcinoma
Zhou, H., Zhang, L., Luo, W., Hong, H., Tang, D., Zhou, D., Zhou, L., & Li, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1050774 · Cited by 21
“progression, suggesting that pyroptosis restricts BLCA development, similar to that in HCC, colorectal cancer (CRC) and gastric cancer (GC) (Allen et al., 2010; Williams et al., 2015; Chu et al., 2016; Qiu et al., 2017).”
BackgroundQian, X., Tang, J., Chu, Y., Chen, K., Liang, C., Shen, C., & Li, L. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s337089 · Cited by 17
Cao, R., Zhou, J., Liu, J., Wang, Y., Dai, Y., Jiang, Y., Yamauchi, A., Atlas, D., Jin, T., Zhou, J., et al. (2025) · Inflammation · doi:10.1007/s10753-025-02282-9 · Cited by 15
“Interest-ingly, NLRP1 has both protective and harmful effects on colitis, modulating IL-1β and IL-18 levels, and affecting the pathogenic bacterial environment in the colon [19–21].”
Morrison, H. A., Eden, K. B., Trusiano, B., Rothschild, D. E., Qin, Y., Wade, P. A., Rowe, A., Mounzer, C., Stephens, M. C., Hanson, K. M., et al. (2024) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2024.05.004 · Cited by 15
“5,33,55,58 Polyps were identi fi ed by a trained investigator with a dissecting microscope.”
MethodInfluentialSelf-citationNeira, G., Gómez‐Ambrosi, J., Cienfuegos, J. A., Ramírez, B., Becerril, S., Rodríguez, A., Burrell, M. A., Baixauli, J., Mentxaka, A., Casado, M., et al. (2024) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-024-01048-5 · Cited by 15
“Depending on the context and the tissue where its location is analyzed, inflam-masomes can either be considered pro-or anti-tumoral [25, 72].”
The Role of Inflammasome-Associated Innate Immune Receptors in Cancer
Dawson, R., & Jenkins, B. J. (2024) · Immune Network · doi:10.4110/in.2024.24.e38 · Cited by 16
“However, the same meta-analysis indicated that NLRP1 mRNA levels were consistently significantly downregulated across multiple CRC patient datasets (84).”
BackgroundInfluentialInflammasomes in Intestinal Disease: Mechanisms of Activation and Therapeutic Strategies
Scalavino, V., Piccinno, E., Giannelli, G., & Serino, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252313058 · Cited by 13
“Moreover, polymorphisms in the associated with CD, and aberrant activation of the NLRP1 in fl am-masome in CRC [20].”
InfluentialThe Role and Therapeutic Potential of Pyroptosis in Colorectal Cancer: A Review
Fang, Q. Z., Xu, Y., Tan, X., Wu, X., Li, S., Yuan, J., Chen, X., Huang, Q., Fu, K., & Xiao, S. (2024) · Biomolecules · doi:10.3390/biom14070874 · Cited by 14
“The advantageous role of the canonical inflammasome pathway of pyroptosis in CRC has been confirmed in many studies [39,40].”
BackgroundLau, J. M.-F., & Dombrowski, Y. (2017) · Cellular and Molecular Immunology · doi:10.1038/cmi.2017.61 · Cited by 12
Prossomariti, A., Sokol, H., & Ricciardiello, L. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01039 · Cited by 13
Błaszczyk, K., Gajewska, M., Wilczak, J., Kamola, D., Majewska, A., Harasym, J., & Gromadzka-Ostrowska, J. (2018) · European Journal of Nutrition · doi:10.1007/s00394-018-1838-3 · Cited by 13
Martino, L., Holland, L., Christodoulou, E., Kunzelmann, S., Esposito, D., & Rittinger, K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164662 · Cited by 11
Somatic Mutation of NLRP Genes in Gastric and Colonic Cancers
Moon, S. W., Son, H. J., Mo, H. Y., Yoo, N. J., & Lee, S. H. (2021) · Pathology & Oncology Research · doi:10.3389/pore.2021.607385 · Cited by 10
“For example, recent studies identified NLRPs that modulated the mucosal immune response during inflammatory bowel diseaseassociated tumorigenesis [8, 9].”
BackgroundResultZhou, F., Zhang, G. D., Tan, Y., Hu, S. A., Tang, Q., & Pei, G. (2023) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848231176889 · Cited by 12
Davari, F., Shokri‐Shirvani, J., Sepidarkish, M., & Nouri, H. R. (2023) · Apmis · doi:10.1111/apm.13323 · Cited by 11
Mechanism of inflammasomes in cancer and targeted therapies
Gu, Q., Zou, J., Zhou, Y. Y., & Deng, Q. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1133013 · Cited by 12
He, H., Wang, W., Li, L., Zhang, X., Shi, H., Chen, J., Shi, D., Xue, M., & Feng, L. (2023) · Journal of Virology · doi:10.1128/jvi.00589-23 · Cited by 8
Li, X., Wang, Z., Gao, H., Xiao, Y., Li, M., Huang, Y., Liu, G., Guo, Y., Song, L., & Ren, Z. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e21869 · Cited by 14
“One study reported that Nlrp1 inflammasome activation could attenuate both colitis and colitis-associated tumorigenesis [46], while Tye H et al. reported that Nlrp1 exacerbated IBD via inhibiting butyrate producing commensals [47].”
BackgroundFatty Acid and Mineral Receptors as Drug Targets for Gastrointestinal Disorders
Pongkorpsakol, P., Moonwiriyakit, A., & Muanprasat, C. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0205 · Cited by 10
Pyroptosis: Turning Up the Heat on Cancer
Zhang, Z., & Lieberman, J. (2026) · Annual Review of Immunology · doi:10.1146/annurev-immunol-082423-041848 · Cited by 10
Zhan, Y., Li, Q., Li, T., Yu, Q., Li, Y., Cheng, X., Sun, Y., Wang, X., Guo, F., Zhang, H., et al. (2024) · Food Bioscience · doi:10.1016/j.fbio.2024.104613 · Cited by 9
Inflammasomes in the Gut Mucosal Homeostasis
Yao, X., & Meng, G. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-5987-2_6 · Cited by 8
“More interestingly, the researchers found that the aggravated colitis was transmissible to WT cagemates through cohousing, which indicated that an outgrowth of colitogenic microbiota was induced in the absence of NLRP1 [83].”
BackgroundInfluentialKelm, M., Burkard, N., Hörner, M., Kollmann, C., Otto, C., Saravi, B., Seubert, A. C., Forchel, F., Kohler, T. N., Penner, M., et al. (2025) · Mucosal Immunology · doi:10.1016/j.mucimm.2025.08.003 · Cited by 6
Zong, J., Wang, Y., Pan, S., Yang, Y., Peng, J., Li, F., Xu, L., Li, S., & Qian, W. (2023) · International Journal of Clinical Practice · doi:10.1155/2023/2250055 · Cited by 6
Chen, Z., Han, Z., Nan, H., Fan, J., Zhan, J., Zhang, Y. L., Zhu, H., Cao, Y. J., Shen, X., Xue, X., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.904464 · Cited by 7
“On the contrary, the occurrence of colon cancer is inhibited by DCA, which could restore the expression of NALP1, indicating that NALP1 is a potential therapeutic marker for colorectal carcinoma (17, 18).”
BackgroundLi, H., Chang, X., Wang, H., Peng, B., Wang, J., Zhang, P., & Zhang, L. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.934835 · Cited by 6
“The expression level of NLRP1 in colorectal cancer tissues is significantly lower than that in adjacent normal tissues, and NLRP1 can inhibit tumorigenesis of colorectal cancer (35).”
BackgroundZhou, T., Wang, T., Zeng, K., Qin, R., Jin, Y., Chen, P., & Ju, G. (2022) · Gene · doi:10.1016/j.gene.2022.146243 · Cited by 6
Tan, J.-X., Li, J., & Yunquan, Z. (2023) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/163581 · Cited by 6
Inflammatory cells implicated in neoplasia development in idiopathic inflammatory bowel disease
Hashash, J. G., & Hartman, D. J. (2017) · Cellular Immunology · doi:10.1016/j.cellimm.2017.11.004 · Cited by 6
Aljohani, H., Anbarserry, D., Mosli, M. H., Ujaimi, A., Bakhshwin, D., Elango, R., & Alharthi, S. (2025) · Biomedicines · doi:10.3390/biomedicines13020459 · Cited by 4
“These findings are consistent with a model whereby multiple NLR inflammasomes attenuate disease pathobiology through modulating IL-1 β and IL18 levels in the colon [53].”
Clinical signature and associated immune metabolism of NLRP1 in pan‐cancer
Liao, Y., Yang, P., Yang, C., Zhuang, K., Fahira, A., Wang, J., Liu, Z., Lin, Y., & Huang, Z. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70100 · Cited by 5
Zeng, Z., Feng, M., He, F., Zhang, E., Li, X., & Cao, Z. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1481111 · Cited by 8
Kuriakose, B. B., Zwamel, A. H., Mutar, A. A., Uthirapathy, S., Bishoyi, A. K., Naidu, K. S., Hjazi, A. M., Nakash, P., Arya, R., & Almalki, S. G. (2025) · Seminars in Oncology · doi:10.1016/j.seminoncol.2025.152337 · Cited by 4
Targeting pattern recognition receptors for cancer therapy: Mechanisms and strategies
Ouyang, D., Chen, R., Xie, H., Yang, X., Li, Q., & Chen, J. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.09.007 · Cited by 3
Inflammasome-independent functions of NAIPs and NLRs in the intestinal epithelium
Scarfe, L., Mackie, G. M., & Maslowski, K. M. (2021) · Biochemical Society Transactions · doi:10.1042/bst20210365 · Cited by 7
Inflammasomes in Myeloid Cells: Warriors Within
Jha, S., Brickey, W. J., & Ting, J. P.-Y. (2017) · ASM Press eBooks · doi:10.1128/9781555819194.ch17 · Cited by 4
Culture conditions of mouse ESCs impact the tumor appearance in vivo
Tian, C., Wang, J., Ye, X., Chen, J., Zheng, R., Yu, H., Li, J., Yin, G., Liu, L., Zhao, N., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112645 · Cited by 4
Vanhove, W., Peeters, P. M., Cleynen, I., Assche, G. V., Ferrante, M., Vermeire, S., & Arijs, I. (2017) · Inflammasome · doi:10.1515/infl-2017-0001 · Cited by 6
NLRPs and tumor: research progress from molecular mechanisms to clinical applications
Song, L., Cao, Y., & Tao, Y. (2025) · Oncogene · doi:10.1038/s41388-025-03642-3 · Cited by 4
“In AOM/DSS-induced murine CRC models, Nlrp1b – / – mice exhibit exacerbated in fl am-mation, increased morbidity, and enhanced tumorigenesis, accompanied by reduced intestinal IL-1 β and IL-18 levels [134].”
Loss of B3GAT1/HNK-1 disrupts glioma-CD8+ T cell immune synapse formation for immune escape
Duan, J., Lin, Y., He, Z., Schachner, M., & Lin, S. L. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115877 · Cited by 2
Parsa, S., Sarkani, E. O., Chaleshtori, Z. M., Darash, S., Fotros, N., Iraj, K. M., Ehsani, F. Z., Naeini, Y. M., Yahyazadeh, S., Fatehpour, M., et al. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116454 · Cited by 3
Boaru, D. L., Castro-Martinez, P. D., García-Montero, C., Fraile‐Μartinez, O., Alhaddadin, M. N. M., Barrena-Blázquez, S., López-González, L., Tasende, C., Hurtado, R. A., Giménez, T. R., et al. (2026) · MedComm · doi:10.1002/mco2.70844 · Cited by 2
“Similarly, miR-145 has been identified as a regulator of GSDMD in the signaling axis, thus representing a potential therapeutic target for restoring pyroptosis and suppressing tumor cell proliferation [ 284, 285 ].”
Zhang, L., Wang, J., Guo, Y. P., Yue, H., & Zhang, M. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e24415 · Cited by 2
Jiang, P., Fan, J., Huang, S., Liu, L., Bai, M., Sun, Q., Shen, J., Zhang, N., Liu, D., Zhou, N., et al. (2023) · PeerJ · doi:10.7717/peerj.16631 · Cited by 2
Colorectal Cancer and NLRP-Current Knowledge
Ajdukovic, J. (2018) · Immunome Research · doi:10.4172/1745-7580.1000153 · Cited by 2
“NLRP1 plays a protective role during experimental colitis and colitis-associated tumorgenesis in the mouse [8,13].”
BackgroundThe Role of Pyroptosis in Colorectal Cancer: From Mechanisms to Therapeutic Opportunities
Xie, H., Deng, X., & Li, Q. (2025) · Cancer Management and Research · doi:10.2147/cmar.s572874 · Cited by 1
“23,26 As the research revealed, low expression of NLRP1 is common in colorectal cancer, and 5-aza-2-deoxycytidine can enhance the expression of NLRP1 to inhibit colon cancer, suppressing the tumor growth.”
Rébé, C., Perrichet, A., & Ghiringhelli, F. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91802-2.00009-8 · Cited by 1
Role of the Inflammasome in Cancer
Terlizzi, M., Colarusso, C., Pinto, A., & Sorrentino, R. (2020) · Springer eBooks · doi:10.1007/978-3-030-30845-2_15 · Cited by 1
Costa, F. R. C. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2018.tde-18072018-184733 · Cited by 1
Hidrogenación catalítica de aceites vegetales
Gutiérrez-Ortiz, J. I., González, C. A. L., & González-Velasco, J. R. (1997) · Alimentación, equipos y tecnología · Cited by 2
NAIP and CARD-only proteins in inflammasome signaling
Matusiak, M. (2015) · Ghent University Academic Bibliography (Ghent University)
Microbial DNA regulates intestinal homeostasis via the AIM2 inflammasome
(2016) · Receptors & Clinical Investigation · doi:10.14800/rci.1268 · Cited by 1
“Previous studies have shown that NLRP3, NLRP6, and NLRP1 protect mice from colitis and colorectal tumorigenesis in an inflammasome-dependent manner [27-31] .”
BackgroundDawson, R., & Jenkins, B. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85563-1.00007-1
Villaseñor, T., Valle‐García, D., Pop, R. T., Osio-Becerro, V. E., Meza‐Sosa, K. F., Serrano, C., de León‐Guerrero, S. D., Hernández‐Pando, R., Nava, P., Kuijjer, M. L., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.02.16.528051
Habibipour, L., Sadeghi, M., Raghibi, A., Khorasani, A. M., Mousavi, P., & Sanadgol, N. (2024) · Research Square · doi:10.21203/rs.3.rs-4363294/v1
Chen, F.-W., Wu, Y.-L., Cheng, C.-C., Hsiao, Y.-W., Chi, J.-Y., Hung, L.-Y., Chang, C.-P., Lai, M.-D., & Wang, J.-M. (2024) · Figshare · doi:10.6084/m9.figshare.26669988
Chen, F.-W., Wu, Y.-L., Cheng, C.-C., Hsiao, Y.-W., Chi, J.-Y., Hung, L.-Y., Chang, C.-P., Lai, M.-D., & Wang, J.-M. (2024) · Figshare · doi:10.6084/m9.figshare.26669985
Chen, F.-W., Wu, Y.-L., Cheng, C.-C., Hsiao, Y.-W., Chi, J.-Y., Hung, L.-Y., Chang, C.-P., Lai, M.-D., & Wang, J.-M. (2024) · Figshare · doi:10.6084/m9.figshare.26669994
Chen, F.-W., Wu, Y.-L., Cheng, C.-C., Hsiao, Y.-W., Chi, J.-Y., Hung, L.-Y., Chang, C.-P., Lai, M.-D., & Wang, J.-M. (2024) · Figshare · doi:10.6084/m9.figshare.26669991
Ciblage de l'IL-1beta pour améliorer l'efficacité de la chimio-immunothérapie dans le cancer
Perrichet, A. (2024) · theses.fr (ABES) · doi:10.70675/b9026a2bzb830z46f0z8122z216dad542b24
Fungi and colorectal cancer: from dysregulation to clinical translation
Wu, Y., Han, S., Jing, Z., & Min, F. (2026) · Gut Pathogens · doi:10.1186/s13099-026-00835-3
“Inflammasomes are multi-protein complexes that form in response to fungal PRR recognition [53, 54].”
Abacar, K., Macleod, T., Alıbaz-Öner, F., Direskeneli, H., & McGonagle, D. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1758222
Metadata
- Authors
- Williams, T. M., Leeth, R. A., Rothschild, D. E., Coutermarsh-Ott, S. L., McDaniel, D. K., Simmons, A. E., Heid, B., Cecere, T. E., & Allen, I. C.
- Affiliations
- Virginia–Maryland College of Veterinary Medicine (US)
- Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech , Blacksburg, VA 24061
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-04-01
- Volume
- 194
- Issue
- 7
- Pages
- 3369-3380
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- PMC
- PMC4369420
- OpenAlex
- W1632263489
- Cited by
- 162
- References
- 62
- Citations by year
- 2026: 5 · 2025: 12 · 2024: 21 · 2023: 20 · 2022: 18 · 2021: 18 · 2020: 9 · 2019: 13 · 2018: 12 · 2017: 18 · 2016: 9 · 2015: 6
- FWCI
- 6.52
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of General Medical Sciences (R25GM072767, R25GM066534)
- National Institute of Diabetes and Digestive and Kidney Diseases (K01DK092355)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- NLRP1, inflammasome, colitis, colitis-associated tumorigenesis, inflammatory bowel disease, colon cancer, IL-1β, IL-18, colonic epithelial cells, gene expression dysregulation, host immune response
- MeSH terms
- NLR Proteins, Animals, Biopsy, Cell Transformation, Neoplastic, Colitis, Colitis, Ulcerative, Colonic Neoplasms, Disease Models, Animal, Humans, Male, Retrospective Studies, Gene Expression, Mice, Knockout, Disease Progression, Interleukin-18, Adaptor Proteins, Signal Transducing, Apoptosis Regulatory Proteins, Mice, Interleukin-1beta, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.